Effect of WT1 gene silencing on the tumorigenicity of human glioblastoma multiforme cells: Laboratory investigation

Journal of Neurosurgery

Volumn 112, Issue 1, 2010, Pages 18-25

  Clark, Aaron J ^a   Ware, Joy L ^a   Chen, Mike Y ^a   Graf, Martin R ^a   Van Meter, Timothy E ^a   Dos Santos, Wagner G ^a   Fillmore, Helen L ^a   Broaddus, William C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Glioblastoma multiforme; Nude mice; Short hairpin RNA; Tumorigenicity; Wilms tumor 1

Indexed keywords

SHORT HAIRPIN RNA; WT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENICITY; CELL INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GLIOBLASTOMA; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS; WT1 PROTEINS;

EID: 75749113779     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2008.11.JNS08368     Document Type: Article

References (35)

1. Algar EM, Khromykh T, Smith SI, Blackburn DM, Bryson GJ, Smith PJ: A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12:1005-1014, 1996
2. Burger PC, Heinz ER, Shibata T, Kleihues P: Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 68:698-704, 1988
3. Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, Uyehara-Lock J, et al: Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors. Clin Cancer Res 8:180-187, 2002
4. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome-11 Wilms' tumor locus. Cell 60:509-520, 1990
5. Central Brain Tumor Registry of the United States: Primary Brain Tumors in the United States Statistical Reports, 1998-2002. Hinsdale, IL: Central Brain Tumor Registry of the United States, 2006 (http://www.cbtrus.org/reports//2005- 2006/2006report.pdf) [Accessed 11 November 2008]
6. Clark AJ, Chan DC, Chen MY, Fillmore H, Dos Santos WG, Van Meter TE, et al: Down-regulation of Wilms' tumor 1 expression in glioblastoma cells increases radiosensitivity independently of p53. J Neurooncol 83:163-172, 2007
7. Clark AJ, Dos SW, McCready J, Chen MY, Van Meter TE, Ware JL, et al: Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status. J Neurosurg 107:586-592, 2007
8. Dennis SL, Manji SSM, Carrington DP, Scarcella DL, Ashley DM, Smith PJ, et al: Expression and mutation analysis of the Wilms' tumor 1 gene in human neural tumors. Int J Cancer 97:713-715, 2002
9. Fraizer G, Leahy R, Priyadarshini S, Graham K, Delacerda J, Diaz M: Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene. Int J Oncol 24:461-471, 2004
10. Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, et al: Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme. Neuro Oncol 7:164-176, 2005
11. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE: Alternative splicing and genomic structure of the Wilms-tumor gene-WT1. Proc Natl Acad Sci U S A 88:9618-9622, 1991
12. Han Y, San Marina S, Liu J, Minden MD: Transcriptional activation of c-myc proto-oncogene by WT1 protein. Oncogene 23:6933-6941, 2004
13. Hosono S, Gross I, English MA, Hajra KM, Fearon ER, Licht JD: E-cadherin is a WT1 target gene. J Biol Chem 275:10943-10953, 2000
14. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, et al: Wt1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute-leukemia. Blood 84:3071-3079, 1994
15. Jomgeow T, Oji Y, Tsuji N, Ikeda Y, Ito K, Tsuda A, et al: Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro. Cancer Sci 97:259-270, 2006
16. Larsson SH, Charlieu JP, Miyagawa K, Engelkamp D, Rassoulzadegan M, Ross A, et al: Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391-401, 1995
17. Liu XW, Gong LJ, Guo LY, Katagiri Y, Jiang H, Wang ZY, et al: The Wilms' tumor gene product WT1 mediates the down-regulation of the rat epidermal growth factor receptor by nerve growth factor in PC12 cells. J Biol Chem 276:5068-5073, 2001
18. Louis DN, Gusella JF: A Tiger Behind Many Doors - Multiple genetic pathways to malignant glioma. Trends Genet 11:412-415, 1995
19. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DM, Cavenee WK, et al: Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311-1333, 2001
20. Menke AL, Riteco N, van Ham RC, de Bruyne C, Rauscher FJ III, van der Eb AJ, et al: Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells. Oncogene 12:537-546, 1996
21. Menke AL, van der Eb AJ, Jochemsen AG: The Wilms' tumor 1 gene: oncogene or tumor suppressor gene? Int Rev Cytol 181:151-212, 1998
22. Menssen HD, Bertelmann E, Bartelt S, Schmidt RA, Pecher G, Schramm K, et al: Wilms' tumor gene (WT1) expression in lung cancer, colon cancer and glioblastoma cell lines compared to freshly isolated tumor specimens. J Cancer Res Clin Oncol 126:226-232, 2000
23. Misra A, Chattopadhyay P, Dinda AK, Sarkar C, Mahapatra AK, Hasnain SE, et al: Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations. J Neurooncol 48:1-12, 2000
24. Miyoshi Y, Ando A, Egawa C, Taguchi T, Tamaki Y, Tamaki H, et al: High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients. Clin Cancer Res 8:1167-1171, 2002
25. Morris JF, Madden SL, Tournay OE, Cook DM, Sukhatme VP, Rauscher FJ III: Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. Oncogene 6:2339-2348, 1991
26. Oji Y, Suzuki T, Nakano Y, Maruno M, Nakatsuka S, Jomgeow T, et al: Overexpression of the Wilms' tumor gene W T1 in primary astrocytic tumors. Cancer Sci 95:822-827, 2004
27. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, et al: Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65:4051-4058, 2005
28. Richard DJ, Schumacher V, Royer-Pokora B, Roberts SG: Par4 is a coactivator for a splice isoform-specific transcriptional activation domain in WT1. Genes Dev 15:328-339, 2001
29. Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, et al: Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol 8:205-214, 2006
30. Sarkaria JN, Carlson BL, Schroeder MA, Grogan P, Brown PD, Giannini C, et al: Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response. Clin Cancer Res 12:2264-2271, 2006
31. Smith SI, Down M, Boyd AW, Li CL: Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice. Cancer Res 60:808-814, 2000
32. Tatsumi N, Oji Y, Tsuji N, Tsuda A, Higashio M, Aoyagi S, et al: Wilms' tumor gene WT1-shRNA as a potent apoptosis-inducing agent for solid tumors. Int J Oncol 32:701-711, 2008
33. Tuna M, Chavez-Reyes A, Tari AM: HER2/neu increases the expression of Wilms' Tumor 1 (WT1) protein to stimulate S-phase proliferation and inhibit apoptosis in breast cancer cells. Oncogene 24:1648-1652, 2005
34. Wagner N, Wagner KD, Schley G, Coupland SE, Heimann H, Grantyn R, et al: The Wilms' tumor suppressor WT1 is associated with the differentiation of retinoblastoma cells. Cell Growth Differ 13:297-305, 2002
35. Zapata-Benavides P, Tuna M, Lopez-Berestein G, Tari AM: Downregulation of Wilms' tumor 1 protein inhibits breast cancer proliferation. Biochem Biophys Res Commun 295:784-790, 2002